tiprankstipranks
Trending News
More News >
Ventana Global (VNTA)
OTHER OTC:VNTA
US Market

Ventana Global (VNTA) Price & Analysis

Compare
7 Followers

VNTA Stock Chart & Stats

$0.04
>-$0.01(-72.22%)
At close: 4:00 PM EST
$0.04
>-$0.01(-72.22%)

VNTA FAQ

What was Ventana Global’s price range in the past 12 months?
Ventana Global lowest stock price was $0.01 and its highest was $0.12 in the past 12 months.
    What is Ventana Global’s market cap?
    Ventana Global’s market cap is $110.13K.
      When is Ventana Global’s upcoming earnings report date?
      The company’s upcoming earnings report date is not yet available.
      How were Ventana Global’s earnings last quarter?
      Currently, no data Available
      Is Ventana Global overvalued?
      According to Wall Street analysts Ventana Global’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
        Does Ventana Global pay dividends?
        Ventana Global does not currently pay dividends.
        What is Ventana Global’s EPS estimate?
        Ventana Global’s EPS estimate for its next earnings report is not yet available.
        How many shares outstanding does Ventana Global have?
        Ventana Global has 2,753,350 shares outstanding.
          What happened to Ventana Global’s price movement after its last earnings report?
          Currently, no data Available
          Which hedge fund is a major shareholder of Ventana Global?
          Currently, no hedge funds are holding shares in VNTA
          What is the TipRanks Smart Score and how is it calculated?
          Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

            Company Description

            Ventana Global

            Ventana Biotech, Inc., a development stage biotech company, identifies, evaluates, acquires, develops, and partners commercialization of intellectual property in the area of drug candidates for personalized medicine. The company focuses in the areas of anti-obesity and related illnesses. The company holds rights for the formula for a medicament containing chewing gum with a composition of the extract of hoodia gordonii and 2-hydroxyoleic acid for the treatment of obesity, hypertension, and other metabolic disorders. The company develops appetite suppressant chewing gums, including the low dosage product for the over-the-counter market and the high dosage product for distribution by pharmacists. It intends to market low dosage product though drug and health food stores. The company was formerly known as Personalica, Inc. and changed its name to Ventana Biotech, Inc. in October 2008. Ventana Biotech, Inc. was founded in 1989 and is based in Butschwil, Switzerland.
            Similar Stocks
            Company
            Price & Change
            Follow
            Tianci International
            Bolt Projects Holdings
            Fusemachines
            Bayview Acquisition Corp Class A
            Popular Stocks